Search Results - "Chung, Da Rae"

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019 by Streinu-Cercel, Anca, Săndulescu, Oana, Preotescu, Liliana-Lucia, Kim, Jin Yong, Kim, Yeon-Sook, Cheon, Shinhye, Jang, Young Rock, Lee, Sang Joon, Kim, Sung Hyun, Chang, Ilsung, Suh, Jee Hye, Lee, Seul Gi, Kim, Mi Rim, Chung, Da Rae, Kim, Han Na, Streinu-Cercel, Adrian, Eom, Joong Sik

“…Abstract Background Regdanvimab (CT-P59) is a monoclonal antibody with neutralizing activity against severe acute respiratory syndrome coronavirus 2…”
Get full text

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019 by Kim, Jin Yong, Săndulescu, Oana, Preotescu, Liliana-Lucia, Rivera-Martínez, Norma E, Dobryanska, Marta, Birlutiu, Victoria, Miftode, Egidia G, Gaibu, Natalia, Caliman-Sturdza, Olga, Florescu, Simin-Aysel, Shi, Hye Jin, Streinu-Cercel, Anca, Streinu-Cercel, Adrian, Lee, Sang Joon, Kim, Sung Hyun, Chang, Ilsung, Bae, Yun Ju, Suh, Jee Hye, Chung, Da Rae, Kim, Sun Jung, Kim, Mi Rim, Lee, Seul Gi, Park, Gahee, Eom, Joong Sik

“…Abstract Background We evaluated clinical effectiveness of regdanvimab (CT-P59), a severe acute respiratory syndrome coronavirus 2 neutralizing monoclonal…”
Get full text